Post Hepatectomy Liver Failure: Concept of Management

Journal of Gastrointestinal Cancer

Volumn 45, Issue 4, 2014, Pages 405-413

  Yadav, Kaushal ^a   Shrikhande, Shailesh ^a   Goel, Mahesh ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Future liver remnant (FLR); Hepatocellular carcinoma; Posthepatectomy liver failure (PHLF)

Indexed keywords

ACETYLCYSTEINE; IRINOTECAN;

ACUTE LIVER FAILURE; ALGORITHM; ARTIFICIAL EMBOLISM; CHEMOEMBOLIZATION; CHEMOTHERAPY ASSOCIATED STEATOHEPATITIS; CHOLESTASIS; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DISEASE SEVERITY; DRUG INDUCED DISEASE; FATTY LIVER; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; LUNG FUNCTION; MEDLINE; PATHOGENESIS; PORTAL VEIN; PORTAL VEIN THROMBOSIS; POSTHEPATECTOMY LIVER FAILURE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; STANDARDIZATION; ADVERSE EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

HEPATECTOMY; HUMANS; LIVER FAILURE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84914158118     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-014-9646-3     Document Type: Review

References (61)

1. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229:322–30.
2. Belghiti J, Hiramatsu J, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38–46.
3. Jarnagin W, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406.
4. Thompson HH, Tompkins RK, Longmire WP. Major hepatic resection. A 25-year experience. Ann Surg. 1983;197:375–88.
5. Reddy SK, Barbas AS, Turley RS, Steel JL, Tsung A, Marsh JW, et al. A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford). 2011;13:494–502.
6. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125–35.
7. Benzoni E, Lorenzin D, Baccarani U, Adani GL, Favero A, Cojutti A, et al. Resective surgery for liver tumor: a multivariate analysis of causes and risk factors linked to postoperative complications. Hepatobiliary Pancreat Dis Int. 2006;5:526–33.
8. Eguchi H, Umeshita K, Sakon M, Nagano H. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure. Dig Dis Sci. 2000;45:1383–8.
9. Balzan S, Belghiti J, Farges O, et al. The “50-50 Criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–9.
10. Paugam-Burtz C, Janny S, Delefosse D, Dahmani S, Dondero F, Mantz J, et al. Prospective validation of the ‘fifty-fifty’ criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg. 2009;249:124–8.
11. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–62.
12. Rahbari NN, Garden OJ, Padbury R, Brooke- Smith M, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.
13. Nadalin S, Testa G, Malago M, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl. 2004;10:1024–9.
14. Suc B, Panis Y, Belghiti J, Fekete F. ‘Natural history’ of hepatectomy. Br J Surg. 1992;79:39–42.
15. Van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malagó M, Jalan R, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 2008;28:767–80.
16. Benzoni E, Lorenzin D, Baccarani U, et al. Resective surgery for liver tumor: a multivariate analysis of causes and risk factors linked to postoperative complications. Hepatobiliary Pancreat Dis Int. 2006;5:526–33.
17. Van den Broek MAJ, Olde Damink SWM, Dejong CHC, Lang H, et al. Liver failure after partial hepatic resection: definition pathophysiology, risk factors and treatment. Liver Int. 2008;26(8):767–80.
18. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292–8.
19. Van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved 1H MR Spectroscopy. Radiology. 2010;256:159–68.
20. Saiki S, Chijiiwa K, Komura M, Yamaguchi K, Kuroki S, Tanaka M. Preoperative internal biliary drainage is superior to external biliary drainage in liver regeneration and function after hepatectomy in obstructive jaundiced rats. Ann Surg. 1999;230(5):655–62.
21. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg. 2000;135:302–8.
22. Yamanaka N, Okamoto E, Kawamura E, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology. 1993;18:79–85.
23. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.
24. EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56:908–43.
25. Rubbia-Brandt L, Mentha G, Terris B. A sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg. 2006;202:199–200.
26. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–72.
27. Roche A. Therapy of HCC-TACE for liver tumor. Hepatogastroenterology. 2001;48:3–7.
28. Yun Quan L, Yi W, Han C, Meng Chao W. Influence of preoperative transcather chemoembolization on liver resection in resectable hepatocellular carcinoma. HBPD Int. 2002;1:523–6.
29. Ferrero A, Viganò L, Polastri R. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31:1643–51.
30. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1271–80.
31. Ferrero A, Vigano L, Polastri R, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31:1643–51.
32. Suda K, Ohtsuka M, Ambiru S, et al. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am J Surg. 2009;197:752–8.
33. Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg. 2012;29:6–17.
34. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–9.
35. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl. 2005;11:594–605.
36. Otsuka Y, Duffy JP, Saab S, Farmer DG, Gabriel RM, Hiatt JR, et al. Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl. 2007;13:672–9.
37. Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR. Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg. 2008;143:247–53.
38. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.
39. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005;62:2295–304.
40. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–21.
41. Farges O, Belghiti J. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208–17.
42. Belghiti J. Arguments for a selective approach of preoperative portal vein embolization before major hepatic resection. J Hepatobiliary Pancreat Surg. 2004;11:21–4.
43. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188(3):304–9.
44. Kubota K. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81.
45. May BJ, Madoff DC. Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol. 2012;29(2):81–9.
46. Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of two stage hepatectomy in patients with initially unresectable colorectal liver metastasis. HPB. 2013;17(7):483–91.
47. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–85.
48. Qiu Y-D, B J-L, Fang-Gui X, Ding Y-T. Effect of preoperative biliary drainage on malignant obstructive jaundice: a meta-analysis. World J Gastroenterol. 2011;17(3):391–6.
49. Kanai M, Nimura Y, Kamiya J, et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery. 1996;119:498–504.
50. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620–5.
51. Dixon E, Vollmer Jr CM, Bathe OF, Sutherland F. Vascular occlusion to decrease blood loss during hepatic resection. Am J Surg. 2005;190:75–86.
52. Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg. 1996;224:155–61.
53. Gurusamy KS, Kumar Y, Pamecha V, Sharma D, Davidson BR. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev 2009;CD007629.
54. Garwood RA, Sawyer RG, Thompson L, Adams RB. Infectious complications after hepatic resection. Am Surg. 2004;70:787–92.
55. Vyhnánek F et al. Postoperative nutritional support in liver surgery: effects of specialized parenteral nutrition enriched with branched-chain amino acids following liver resections for colorectal carcinoma metastases. Rozhl Chir. 2008;87(1):21–5.
56. Jegatheeswaran S, Siriwardena AK. Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB. 2011;13:71–8.
57. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856–64.
58. Mumtaz K, Azam Z, Hamid S, et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int. 2009;3:563–70.
59. Robinson SM, Saif R, Sen G, French JJ, Bryon C, et al. N-acetylcysteine administration does not improve patient outcome after liver resection. HPB. 2013;15:457–62.
60. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev 2004, Issue 1. Art. No.: CD003628.
61. Hughes RD, Mitry RR, Dhawan A. Current status of hepatocyte transplantation. Transplantation. 2012;93:342–7.